glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results Effects of on Heart Failure in Diabetes and Chronic Disease in the Kidney Outcomes With Glucagon-Like Peptide-1
Description
[DOI] [PubMed] [Google Scholar] 18.Liu Z-Z, Duan X-X, Yuan M-C, Yu J, Hu X, Han X, et al
Due to the limited number of eligible studies, researchers were unable to stratify their analysis by indication of GLP-1 medications or to conduct further examination of studies utilising certain diagnostic modalities such as breath testing
Jastreboff AM, Kushner RF
Glucagon-like peptide-1 receptor agonists and safety in the preconception period
Get started with GLP-1 medications for as little as $149/month, pricing for select medications requires use of third-party savings card
